DrugPatentWatch Database Preview

Carboplatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carboplatin and what is the scope of carboplatin patent protection?

Carboplatin is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Corden Pharma, Accord Hlthcare, Actavis Totowa, Akorn, Eugia Pharma, Fresenius Kabi Oncol, Gland Pharma Ltd, Ingenus Pharms Llc, Mylan Institutional, Nanjing King-friend, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Twelve suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for carboplatin

US Patents:	0
Tradenames:	2
Applicants:	25
NDAs:	35
Drug Master File Entries:	18
Suppliers / Packagers:	12
Bulk Api Vendors:	80
Clinical Trials:	2,026
Patent Applications:	181
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for carboplatin
DailyMed Link:	carboplatin at DailyMed

Pharmacology for carboplatin

Ingredient-type	Platinum-containing Compounds
Drug Class	Platinum-based Drug

Medical Subject Heading (MeSH) Categories for carboplatin

Antineoplastic Agents

Cross-Linking Reagents

Synonyms for carboplatin

(SP-4-2)-Diamimine[1,1-cyclobutanedi(carboxylato-kO)(2-)]platinum

(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum

1,1-Cyclobutanedicarboxylate

1,1-Cyclobutanedicarboxylate diammine platinum (II)

1,1-Cyclobutanedicarboxylate diammine platinum(II)

1,1-CYCLOBUTANEDICARBOXYLATODIAMMINE PLATINUM

1,1-Cyclobutanedicarboxylatodiammineplatinum

1,1-Cyclobutanedicarboxylatodiammineplatinum (II)

1,1-Cyclobutanedicarboxylatodiammineplatinum(II)

10329-EP2269988A2

10329-EP2269989A1

10329-EP2270008A1

10329-EP2272827A1

10329-EP2275102A1

10329-EP2275412A1

10329-EP2275413A1

10329-EP2275420A1

10329-EP2277876A1

10329-EP2280012A2

10329-EP2281815A1

10329-EP2287156A1

10329-EP2292233A2

10329-EP2292614A1

10329-EP2292615A1

10329-EP2292617A1

10329-EP2295055A2

10329-EP2295416A2

10329-EP2295426A1

10329-EP2295427A1

10329-EP2298748A2

10329-EP2298764A1

10329-EP2298765A1

10329-EP2298768A1

10329-EP2298772A1

10329-EP2298778A1

10329-EP2301536A1

10329-EP2301538A1

10329-EP2301928A1

10329-EP2301933A1

10329-EP2305243A1

10329-EP2305640A2

10329-EP2305642A2

10329-EP2305671A1

10329-EP2308812A2

10329-EP2308833A2

10329-EP2308839A1

10329-EP2308855A1

10329-EP2308861A1

10329-EP2311453A1

10329-EP2311455A1

10329-EP2311807A1

10329-EP2311808A1

10329-EP2311825A1

10329-EP2311827A1

10329-EP2311829A1

10329-EP2311840A1

10329-EP2314590A1

10329-EP2316452A1

10329-EP2316831A1

10329-EP2316832A1

10329-EP2316833A1

10329-EP2316834A1

10329-EP2374454A1

41575-94-4

575C944

6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione

6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione diamine

7,7-diamino-[?]spiro[3.5]nonane-5,9-dione

7,7-dimethyl-6,8-dioxa-7$l^{4}-platinaspiro[3.5]nonane-5,9-dione

70903-55-8

AB0013326

AB01273939-01

AB01274771_03

AB01274771-01

AB01274771-02

AB01568249_01

AC-1457

AC1L1DYT

AC1L20N7

AC1NR9YB

AC1O7G18

AK136131

AKOS015905301

AKOS022185820

AKOS024457202

Ambap41575-94-4

AN-265

AOB5507

AS-13313

azane; cyclobutane-1,1-dicarboxylic acid; platinum

BC204693

BDBM50274681

BDBM92389

BG3F62OND5

BSPBio_003145

C 2538

C-21145

C6H10N2O4Pt

C6H6O4Pt.2NH3

Carbopaltin

Carboplatin (JAN/USP/INN)

Carboplatin (JP17/USP/INN)

Carboplatin (USAN)

Carboplatin [USAN:INN:BAN:JAN]

Carboplatin [USAN:USP:INN:BAN:JAN]

Carboplatin, British Pharmacopoeia (BP) Reference Standard

Carboplatin, United States Pharmacopeia (USP) Reference Standard

Carboplatine

Carboplatine [French]

Carboplatino

Carboplatino [Spanish]

Carboplatinum

Carboplatinum [Latin]

Caronplatin, 4

CAS-41575-94-4

Cbdca

cbdca(2-)

CCG-204325

CCG-39887

CCRIS 3404

CHEBI:31355

CHEBI:35690

cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum

cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)

cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)

cis-Diammine(1,1-cyclobutanedicarboxylato) platinum

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)

cis-Diammine(cyclobutanedicarboxylato)platinum II

Cis-Diammine(cyclobutanedicarboxylato)platinumII

cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum

cis-diamminecyclobutanedicarboxylatoplatinum(II);

CS-1121

CTK7I5753

cyclobutane dicarboxylate platinum (ii)

cyclobutane-1,1-dicarboxylate

cyclobutane-1,1-dicarboxylate(2-)

cyclobutane-1,1-dicarboxylic acid- platinum(1:1)

cyclobutane-1,1-dicarboxylic acid; platinum

D01363

D0X7HM

DB00958

diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~O~1~,O~1~]platinum

Diammine-1,1-cyclobutane dicarboxylate platinum II

Diammine(1,1-cyclobutanedicarboxylato)platinum (II)

Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum

diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum

DivK1c_000892

DR002048

DSSTox_CID_26742

DSSTox_GSID_46742

DSSTox_RID_81870

DTXSID3046742

DVQHYTBCTGYNNN-UHFFFAOYSA-N

EBD50809

EINECS 255-446-0

Epitope ID:194801

Ercar

EU-0100230

FT-0602925

H876

HMS1921J16

HMS2090M05

HMS2092B22

HMS3260N21

HMS3269H03

HMS502M14

HSDB 6957

HY-17393

I14-2390

IDI1_000892

IUPAC: Azane

JM 8

JM-8

K-8751

KBio1_000892

KBio2_002009

KBio2_004577

KBio2_007145

KBio3_002645

KBioGR_000713

KBioSS_002009

Lopac-C-2538

Lopac0_000230

LP00230

LS-117689

MFCD00070464

MolPort-003-845-609

MolPort-006-147-683

MolPort-035-395-692

NCGC00015223-01

NCGC00015223-02

NCGC00015223-03

NCGC00015223-04

NCGC00015223-05

NCGC00015223-06

NCGC00015223-07

NCGC00015223-08

NCGC00015223-09

NCGC00015223-10

NCGC00093695-01

NCGC00094961-01

NCGC00094961-02

NCGC00094961-03

NCGC00162099-01

NCGC00162099-02

NCGC00167800-01

NCGC00178242-01

NCGC00260915-01

NCGC00263858-02

NCGC00263858-03

NINDS_000892

NSC 201345

NSC 241240

NSC-201345

NSC-241240

NSC-758182

NSC201345

NSC241240

NSC758182

OLESAACUTLOWQZ-UHFFFAOYSA-L

Paraplatin

Paraplatin (Bristol Meyers)

Paraplatin (TN)

Paraplatin-AQ

Paraplatin, Carboplatin

Pharmakon1600-01502106

Platinum, {diammine[1,1-cyclobut

Platinum, {diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-,} (SP-4-2)-

Platinum, diamine(1, 1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-

Platinum, diammine(1,1-cyclobutanedi(carboxylato-kappaO)(2-))-, (SP-4-2)-

Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)

Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-

Platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-

Platinum, diammine[1,1-cyclobutanedi(carboxylato-.kappa.O)(2-)]-, (SP-4-2)-

Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.O,.kappa.O'']-, (SP-4-2)-

Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-

Platinum,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-

Platinum,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-

platinum(+2) cation

Platinum(II), (1, 1-cyclobutanedicar

Platinum(II), (1, 1-cyclobutanedicarboxylato)diammine-, cis-

Platinum(II), (1,1-cyclobutanedicarboxylato)diammine-, cis-

Platinum(II),1-cyclobutanedicarboxylato)diammine-, cis-

RL03611

s1215

SBI-0050218.P002

SC-18620

SCHEMBL2671349

SCHEMBL4964

SPBio_000716

Spectrum_001529

SPECTRUM1502106

Spectrum2_000898

Spectrum3_001503

Spectrum4_000337

Spectrum5_001094

SR-01000076253

SR-01000076253-5

ST24046284

STL451040

Tox21_112586

Tox21_112586_1

Tox21_500230

UNII-BG3F62OND5

W-106301

ZB013490

Tentative approvals for CARBOPLATIN

Applicant	Application No.	Strength	Dosage Form
		450MG/VIAL	INJECTABLE;INJECTION
		150MG/VIAL	INJECTABLE;INJECTION
		50MG/VIAL	INJECTABLE;INJECTION

US Patents and Regulatory Information for carboplatin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	CARBOPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	206775-001	Feb 9, 2017	AP	RX	No	No
Mylan Labs Ltd	CARBOPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	091063-004	Nov 9, 2011	AP	RX	No	No
Watson Labs Teva	CARBOPLATIN	carboplatin	INJECTABLE;INJECTION	076162-002	Oct 14, 2004		DISCN	No	No

Expired US Patents for carboplatin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cordenpharma	PARAPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	020452-004	Jan 15, 2004
Corden Pharma	PARAPLATIN	carboplatin	INJECTABLE;INJECTION	019880-001	Mar 3, 1989
Cordenpharma	PARAPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	020452-001	Jul 14, 2003